Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention F. Markus LewekeJuliane K. MuellerCathrin Rohleder Leading Article 18 July 2018 Pages: 605 - 619
Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease Christoph MuellerAnto P. RajkumarDag Aarsland Therapy in Practice 20 July 2018 Pages: 621 - 635
Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond Verena Isabell LeussinkXavier MontalbanHans-Peter Hartung Review Article 10 July 2018 Pages: 637 - 651
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration? Chiara ZeccaG. BellaviaS. Rossi Original Research Article 12 June 2018 Pages: 653 - 660
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study Ayman TourbahOlivier GoutCarl Arndt Original Research Article Open access 28 May 2018 Pages: 661 - 672
Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database Sophie Billioti de GageCédric CollinMahmoud Zureik Original Research Article Open access 29 June 2018 Pages: 673 - 684
Comment on: “Activating Autophagy as a Therapeutic Strategy for Parkinson’s Disease” Juan Segura-Aguilar Letter to the Editor 27 June 2018 Pages: 685 - 686
Author’s Reply to Segura-Aguilar: Autophagosome maturation not autophagy induction is impaired in neurodegeneration Alan J. FowlerCharbel E.-H. Moussa Letter to the Editor 27 June 2018 Pages: 687 - 688
Nusinersen: A Review in 5q Spinal Muscular Atrophy Sheridan M. Hoy Adis Drug Evaluation 20 July 2018 Pages: 689 - 696